US - "Vaccine advisers to the CDC are meeting Thursday to weigh possible limits on the use of the Johnson &amp; Johnson vaccine because of continued blood clot issues, mostly in young and middle-aged women, according to clinicians familiar with the agenda."Washington Post, 16/12/21
